Overview
STEMCELL Technologies develops specialized cell culture media, cell isolation products, reagents, and instruments for life sciences research, including cell therapy and drug discovery. Their ethically sourced human primary cells from peripheral blood, cord blood, and bone marrow support fundamental and translational research. With over 2500 products like cGMP-compliant media, differentiation kits, and cryopreservation solutions, they enable scalable workflows for T cell therapies, hematopoietic cells, and pluripotent stem cell applications.
Frequently asked questions
- What cGMP-compliant products does STEMCELL offer for cell therapy?
- STEMCELL provides animal origin-free, cGMP-compliant media such as TeSR™-AOF, StemSpan™-AOF, and ImmunoCult™-XF for culture, expansion, and differentiation, along with validated cryopreservation media like CryoStor® CS10 for consistent cell recovery.
- What are STEMCELL's capabilities in pluripotent stem cell research?
- They offer the STEMdiff™ suite for defined, feeder-free differentiation of hPSCs to all three lineages, Vitronectin XF™ surfaces for xeno-free culture with mTeSR™1, TeSR™2, or TeSR™-E8™, and tools for iPSC generation, culture, and applications in drug screening and toxicology.
- What geographies does STEMCELL serve and are products regulatory compliant?
- STEMCELL supports global scientific research with products designed for high compliance and scalability in cell therapy workflows, including cGMP-compliant reagents standardized for reproducible results in research and development.